Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells
Nathan L. Board, Yuan Zhe, Fengting Wu, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 462-470
Open Access | Times Cited: 16

Showing 16 citing articles:

Calcium‐sensing receptor‐ and ADAM10‐mediated klotho shedding is regulated by tetraspanin 5
Zhenan Liu, Joon‐Ho Yoon, Eunyoung Lee, et al.
FEBS Letters (2025)
Open Access
Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells
Zamaneh Hajikhezri, Ioannis Zygouras, Anders Sönnerborg, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Thessa Laeremans, A Janssens, Joeri L. Aerts
Immunotherapy (2025), pp. 1-13
Closed Access
NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption
Nerea Sánchez-Gaona, David Perea, Adrián Curran, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
T Chou, Nishad S. Maggirwar, Matthew D. Marsden
Viruses (2024) Vol. 16, Iss. 7, pp. 1163-1163
Open Access | Times Cited: 4
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
Sheila M. Keating, Brett W. Higgins
Antiviral Research (2024) Vol. 227, pp. 105902-105902
Closed Access | Times Cited: 3
Harnessing natural killer cells to target HIV-1 persistence
Vinita R. Joshi, Marcus Altfeld
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 3, pp. 141-149
Closed Access | Times Cited: 2
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission
Hang Su, April Mueller, Harris Goldstein
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 169-178
Closed Access | Times Cited: 1
Ex vivoandin vivoHIV-1 latency reversal by “Mukungulu,” a protein kinase C-activating African medicinal plant extract
Khumoekae Richard, Zhe Yuan, Hsin‐Yao Tang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
A Comprehensive Engineering Strategy Improves Potency and Manufacturability of a Near Pan-neutralizing Antibody Against HIV
Mohammad M. Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
(2024)
Closed Access | Times Cited: 1
Humanized mice for studying HIV latency and potentially its eradication
Moa Hasler, Roberto F. Speck, Nicole P. Kadzioch
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 3, pp. 157-167
Closed Access
Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells
Ildefonso Sánchez‐Cerrillo, Olga Popova, María Agudo-Lera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Development of a single-chain variable antibody fragment against a conserved region of the SARS-CoV-2 spike protein
Tingyu Gao, Atsushi Irie, Takahisa Kouwaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Eliminates Ex Vivo Reservoirs
L.‐H. Chang, Michael T. Yin, Gregory M. Laird, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Advances in the mathematical modeling of posttreatment control of HIV-1
Bharadwaj Vemparala, Jérémie Guedj, Narendra M. Dixit
Current Opinion in HIV and AIDS (2024) Vol. 20, Iss. 1, pp. 92-98
Closed Access
Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells
Robert van Domselaar, Zamaneh Hajikhezri, Ioannis Zygouras, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top